SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019460
Filing Date
2021-08-11
Accepted
2021-08-11 16:16:23
Documents
47
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20210630_10q.htm   iXBRL 10-Q 622019
2 EXHIBIT 31.1 ex_272540.htm EX-31.1 12159
3 EXHIBIT 31.2 ex_272541.htm EX-31.2 12137
4 EXHIBIT 32.1 ex_272542.htm EX-32.1 4962
5 EXHIBIT 32.2 ex_272543.htm EX-32.2 5102
  Complete submission text file 0001437749-21-019460.txt   3125840

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbla-20210630.xsd EX-101.SCH 30839
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20210630_cal.xml EX-101.CAL 19402
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20210630_def.xml EX-101.DEF 216572
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20210630_lab.xml EX-101.LAB 193888
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20210630_pre.xml EX-101.PRE 234726
11 EXTRACTED XBRL INSTANCE DOCUMENT snbp20210630_10q_htm.xml XML 397391
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 211163614
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences